Literature DB >> 23084956

Cord blood graft engineering.

Colleen Delaney1, Catherine M Bollard, Elizabeth J Shpall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23084956      PMCID： PMC4212641          DOI： 10.1016/j.bbmt.2012.10.015

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  36 in total

1.  In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes.

Authors:  Kyung-Duk Park; Luciana Marti; Joanne Kurtzberg; Paul Szabolcs
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

2.  Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Authors:  Ann M Leen; G Doug Myers; Uluhan Sili; M Helen Huls; Heidi Weiss; Kathryn S Leung; George Carrum; Robert A Krance; Chung-Che Chang; Jeffrey J Molldrem; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Catherine M Bollard
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

3.  Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.

Authors:  T Peled; J Mandel; R N Goudsmid; C Landor; N Hasson; D Harati; M Austin; A Hasson; E Fibach; E J Shpall; A Nagler
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

4.  Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.

Authors:  S N Robinson; J Ng; T Niu; H Yang; J D McMannis; S Karandish; I Kaur; P Fu; M Del Angel; R Messinger; F Flagge; M de Lima; W Decker; D Xing; R Champlin; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

5.  Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.

Authors:  M L Macmillan; B R Blazar; T E DeFor; J E Wagner
Journal:  Bone Marrow Transplant       Date:  2008-10-27       Impact factor: 5.483

6.  Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.

Authors:  M de Lima; J McMannis; A Gee; K Komanduri; D Couriel; B S Andersson; C Hosing; I Khouri; R Jones; R Champlin; S Karandish; T Sadeghi; T Peled; F Grynspan; Y Daniely; A Nagler; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2008-01-21       Impact factor: 5.483

7.  Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.

Authors:  Francesco Frassoni; Francesca Gualandi; Marina Podestà; Anna Maria Raiola; Adalberto Ibatici; Giovanna Piaggio; Mario Sessarego; Nadia Sessarego; Marco Gobbi; Nicoletta Sacchi; Myriam Labopin; Andrea Bacigalupo
Journal:  Lancet Oncol       Date:  2008-08-08       Impact factor: 41.316

8.  Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor.

Authors:  G Bautista; J R Cabrera; C Regidor; R Forés; J A García-Marco; E Ojeda; I Sanjuán; E Ruiz; I Krsnik; B Navarro; S Gil; E Magro; A de Laiglesia; R Gonzalo-Daganzo; T Martín-Donaire; M Rico; I Millán; M N Fernández
Journal:  Bone Marrow Transplant       Date:  2008-10-13       Impact factor: 5.483

9.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.

Authors:  Jonathan Hoggatt; Pratibha Singh; Janardhan Sampath; Louis M Pelus
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113

10.  Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.

Authors:  Trista E North; Wolfram Goessling; Carl R Walkley; Claudia Lengerke; Kamden R Kopani; Allegra M Lord; Gerhard J Weber; Teresa V Bowman; Il-Ho Jang; Tilo Grosser; Garret A Fitzgerald; George Q Daley; Stuart H Orkin; Leonard I Zon
Journal:  Nature       Date:  2007-06-21       Impact factor: 49.962
View more
  4 in total

Review 1.  Cord Blood Banking for Potential Future Transplantation.

Authors:  William T Shearer; Bertram H Lubin; Mitchell S Cairo; Luigi D Notarangelo
Journal:  Pediatrics       Date:  2017-11       Impact factor: 7.124

2.  Epigenetic reprogramming induces the expansion of cord blood stem cells.

Authors:  Pratima Chaurasia; David C Gajzer; Christoph Schaniel; Sunita D'Souza; Ronald Hoffman
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 3.  Concise review: umbilical cord blood transplantation: past, present, and future.

Authors:  Javier Munoz; Nina Shah; Katayoun Rezvani; Chitra Hosing; Catherine M Bollard; Betul Oran; Amanda Olson; Uday Popat; Jeffrey Molldrem; Ian K McNiece; Elizabeth J Shpall
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

4.  Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT.

Authors:  Frédéric Baron; Myriam Labopin; Annalisa Ruggeri; Gerhard Ehninger; Fransesca Bonifazi; Matthias Stelljes; Jaime Sanz; Gernot Stuhler; Alberto Bosi; Nicolaus Kröger; Maria Teresa Van Lint; Arnold Ganser; Edouard Forcade; Mohamad Mohty; Eliane Gluckman; Arnon Nagler
Journal:  Blood Cancer J       Date:  2019-04-12       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.